Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts

Lawton, M; Tan, MM; Ben-Shlomo, Y; Baig, F; Barber, T; Klein, JC; Evetts, SG; Millin, S; Malek, N; Grosset, K; Barker, RA; Williams, N; Burn, DJ; Foltynie, T; Morris, HR; Wood, N; Grosset, DG; Hu, MT-M

Journal article

Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts

Abstract:: OBJECTIVES: To explore the genetics of four Parkinson's disease (PD) subtypes that have been previously described in two large cohorts of patients with recently diagnosed PD. These subtypes came from a data-driven cluster analysis of phenotypic variables. METHODS: We looked at the frequency of genetic mutations in glucocerebrosidase (GBA) and leucine-rich repeat kinase 2 against our subtypes. Then we calculated Genetic Risk Scores (GRS) for PD, multiple system atrophy, progressive supranuclear palsy, Lewy body dementia, and Alzheimer's disease. These GRSs were regressed against the probability of belonging to a subtype in the two independent cohorts and we calculated q-values as an adjustment for multiple testing across four subtypes. We also carried out a Genome-Wide Association Study (GWAS) of belonging to a subtype. RESULTS: A severe disease subtype had the highest rates of patients carrying GBA mutations while the mild disease subtype had the lowest rates (p=0.009). Using the GRS, we found a severe disease subtype had a reduced genetic risk of PD (p=0.004 and q=0.015). In our GWAS no individual variants met genome wide significance (<5×10e-8) although four variants require further follow-up, meeting a threshold of <1×10e-6. CONCLUSIONS: We have found that four previously defined PD subtypes have different genetic determinants which will help to inform future studies looking at underlying disease mechanisms and pathogenesis in these different subtypes of disease

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Lawton, M., Tan, M. M., Ben-Shlomo, Y., Baig, F., Barber, T., Klein, J. C., Evetts, S. G., Millin, S., Malek, N., Grosset, K., Barker, R. A., Williams, N., Burn, D. J., Foltynie, T., Morris, H. R., Wood, N., Grosset, D. G., & Hu, M. T.-M. (2022). Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts. Journal of Neurology, Neurosurgery and Psychiatry, 93(9), 952–959.

MLA Style

Lawton, M, et al. “Genetics of Validated Parkinson’s Disease Subtypes in the Oxford Discovery and Tracking Parkinson’s Cohorts.” Journal of Neurology, Neurosurgery and Psychiatry, vol. 93, no. 9, 2022, pp. 952–59.

Chicago Style

Lawton, M, MM Tan, Y Ben-Shlomo, et al. 2022. “Genetics of Validated Parkinson’s Disease Subtypes in the Oxford Discovery and Tracking Parkinson’s Cohorts.” Journal of Neurology, Neurosurgery and Psychiatry 93 (9): 952–59.
Print